292 related articles for article (PubMed ID: 31324220)
1. Diagnosis and management of individuals with Fetal Valproate Spectrum Disorder; a consensus statement from the European Reference Network for Congenital Malformations and Intellectual Disability.
Clayton-Smith J; Bromley R; Dean J; Journel H; Odent S; Wood A; Williams J; Cuthbert V; Hackett L; Aslam N; Malm H; James G; Westbom L; Day R; Ladusans E; Jackson A; Bruce I; Walker R; Sidhu S; Dyer C; Ashworth J; Hindley D; Diaz GA; Rawson M; Turnpenny P
Orphanet J Rare Dis; 2019 Jul; 14(1):180. PubMed ID: 31324220
[TBL] [Abstract][Full Text] [Related]
2. Neurodevelopmental outcomes in children and adults with Fetal Valproate Spectrum Disorder: A contribution from the ConcePTION project.
Bluett-Duncan M; Astill D; Charbak R; Clayton-Smith J; Cole S; Cook PA; Cozens J; Keely K; Morris J; Mukherjee R; Murphy E; Turnpenny P; Williams J; Wood AG; Yates LM; Bromley RL
Neurotoxicol Teratol; 2023; 100():107292. PubMed ID: 37666366
[TBL] [Abstract][Full Text] [Related]
3. Valproate prescribing practices for women with intellectual disability across Europe.
Watkins L; Reuber M; Perera B; Courtenay K; Banks R; Murphy E; Angus-Leppan H; Shankar R
Acta Neurol Scand; 2021 Jan; 143(1):56-61. PubMed ID: 32813274
[TBL] [Abstract][Full Text] [Related]
4. Modified Xenopus laevis approach (R-FETAX) as an alternative test for the evaluation of foetal valproate spectrum disorder.
Battistoni M; Bacchetta R; Di Renzo F; Metruccio F; Moretto A; Menegola E
Reprod Toxicol; 2022 Jan; 107():140-149. PubMed ID: 34923091
[TBL] [Abstract][Full Text] [Related]
5. Fetal Valproate Syndrome.
Mutlu-Albayrak H; Bulut C; Çaksen H
Pediatr Neonatol; 2017 Apr; 58(2):158-164. PubMed ID: 27422007
[TBL] [Abstract][Full Text] [Related]
6. The lived experience of young adults with Fetal Valproate Spectrum Disorder, and the perspective of their parents: A qualitative study.
Khanom S; Astill D; Astill N; Cozens J; Mann B; Garratt J; Bromley RL
Epilepsy Behav; 2024 Mar; 152():109680. PubMed ID: 38335859
[TBL] [Abstract][Full Text] [Related]
7. Dysmorphic features: an important clue to the diagnosis and severity of fetal anticonvulsant syndromes.
Kini U; Adab N; Vinten J; Fryer A; Clayton-Smith J;
Arch Dis Child Fetal Neonatal Ed; 2006 Mar; 91(2):F90-5. PubMed ID: 16239295
[TBL] [Abstract][Full Text] [Related]
8. Chromatin Imbalance as the Vertex Between Fetal Valproate Syndrome and Chromatinopathies.
Parodi C; Di Fede E; Peron A; Viganò I; Grazioli P; Castiglioni S; Finnell RH; Gervasini C; Vignoli A; Massa V
Front Cell Dev Biol; 2021; 9():654467. PubMed ID: 33959609
[TBL] [Abstract][Full Text] [Related]
9. Establishing or Excluding a Diagnosis of Fetal Valproate Spectrum Disorder is a Multi-layered Process.
Kalim A; Reardon W
Ir Med J; 2021 Jun; 114(6):382. PubMed ID: 35863137
[TBL] [Abstract][Full Text] [Related]
10. [French Expert advice on the management of valproate in childbearing and pregnant women with bipolar disorder].
Samalin L; Arnould A; Boudieu L; Henry C; Haffen E; Drapier D; Anmella G; Pacchiarotti I; Vieta E; Belzeaux R; Llorca PM
Encephale; 2022 Dec; 48(6):624-631. PubMed ID: 36257849
[TBL] [Abstract][Full Text] [Related]
11. In utero antiepileptic drug exposure: fetal death and malformations.
Meador KJ; Baker GA; Finnell RH; Kalayjian LA; Liporace JD; Loring DW; Mawer G; Pennell PB; Smith JC; Wolff MC;
Neurology; 2006 Aug; 67(3):407-12. PubMed ID: 16894099
[TBL] [Abstract][Full Text] [Related]
12. Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child.
Bromley R; Weston J; Adab N; Greenhalgh J; Sanniti A; McKay AJ; Tudur Smith C; Marson AG
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD010236. PubMed ID: 25354543
[TBL] [Abstract][Full Text] [Related]
13. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
14. Teratogenesis of sodium valproate.
Duncan S
Curr Opin Neurol; 2007 Apr; 20(2):175-80. PubMed ID: 17351488
[TBL] [Abstract][Full Text] [Related]
15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
16. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism.
Christensen J; Grønborg TK; Sørensen MJ; Schendel D; Parner ET; Pedersen LH; Vestergaard M
JAMA; 2013 Apr; 309(16):1696-703. PubMed ID: 23613074
[TBL] [Abstract][Full Text] [Related]
17. Risks of neurobehavioral teratogenicity associated with prenatal exposure to valproate monotherapy: a systematic review with regulatory repercussions.
Gentile S
CNS Spectr; 2014 Aug; 19(4):305-15. PubMed ID: 24571806
[TBL] [Abstract][Full Text] [Related]
18. Neurodevelopmental delay in children exposed to antiepileptic drugs in utero: a critical review directed at structural study-bias.
Nicolai J; Vles JS; Aldenkamp AP
J Neurol Sci; 2008 Aug; 271(1-2):1-14. PubMed ID: 18479711
[TBL] [Abstract][Full Text] [Related]
19. Association of Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual Disability.
Bjørk MH; Zoega H; Leinonen MK; Cohen JM; Dreier JW; Furu K; Gilhus NE; Gissler M; Hálfdánarson Ó; Igland J; Sun Y; Tomson T; Alvestad S; Christensen J
JAMA Neurol; 2022 Jul; 79(7):672-681. PubMed ID: 35639399
[TBL] [Abstract][Full Text] [Related]
20. Treating epilepsy in pregnant women.
Eadie MJ
Expert Opin Pharmacother; 2014 Apr; 15(6):841-50. PubMed ID: 24611535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
